FindTrial
Sign In

Clinical outcome of non-curative resection of rectal neuroendocrine tumors

Clinical outcome of non-curative resection of rectal neuroendocrine tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041161
Enrollment
Unknown
Registered
2020-12-20
Start date
2020-12-08
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal neuroendocrine tumors

Interventions

curative resection of rectal neuroendocrine tumors:None
non-curative resection of rectal neuroendocrine tumors:None

Sponsors

Beijing Friendship Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with neuroendocrine tumor diagnosed pathologically after endoscopic resection, regardless of lymphatic vascular invasion or clean cutting edge.

Exclusion criteria

Exclusion criteria: Patients with rectal neuroendocrine carcinoma.

Design outcomes

Primary

MeasureTime frame
serum CEA;serum hemoglobin;IHC of Ki-67;IHC of CgA;IHC of Syn;IHC of D2-40;IHC of CD31;IHC of EVG;IHC of CD56;—

Countries

China

Contacts

Public ContactHu Haiyi

Beijing Friendship Hospital Affiliated to Capital Medical University

werjw@126.com+86 13811185943

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026